SCHEMBL13613622

SCHEMBL13613622

CC1(O)CCc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2C1

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 19/20 0.66
KDR P35968 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4332191 0.80 TRPV1 (0.69) TRPV1KDR
SCHEMBL5130279 0.80 TRPV1 (1.00) TRPV1KDR
SCHEMBL4332089 0.78 TRPV1 (1.00) TRPV1KDR
SCHEMBL4335739 0.78 TRPV1 (1.00) TRPV1KDR
SCHEMBL4343306 0.78 TRPV1 (1.00) TRPV1KDR
SCHEMBL5129577 0.78 TRPV1 (0.66) TRPV1KDR
SCHEMBL5123726 0.77 TRPV1 (0.76) TRPV1KDR
SCHEMBL5123803 0.77 TRPV1 (0.85) TRPV1KDR
SCHEMBL5120380 0.76 TRPV1 (1.00) TRPV1KDR
SCHEMBL5118985 0.75 TRPV1 (0.70) TRPV1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed